Representatives of EMBLEM, EMBL’s exclusive technology and transfer partner, including Dr. Jürgen Bauer, Deputy Managing Director and Group Leader Business Development, and Dr. Julia Dieter, Business Development Manager, joined leading EMBL scientists to present insights into how the application of EMBL technologies and know-how can benefit Israeli companies. In addition, specialists from the Israel Innovation Authority shared details about their Tech Transfer Program, including its grants, terms and conditions.
The following technologies were be presented by leading scientists:
- Synergistic antimicrobial drug combinations against multi-resistant bacteria; Dr. Elisabetta Cacace.
- Spin-off “Cerelixis”: Development of precision crop protection products as basis for sustainable agriculture; Dr. Marianna Vrettou-Schultes and Dr. Jose A. Marquez.